| Rituximab: mechanism of action GJ Weiner Seminars in hematology 47 (2), 115-123, 2010 | 955 | 2010 |
| CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells G Hartmann, GJ Weiner, AM Krieg Proceedings of the National Academy of Sciences 96 (16), 9305-9310, 1999 | 906 | 1999 |
| Building better monoclonal antibody-based therapeutics GJ Weiner Nature Reviews Cancer 15 (6), 361-370, 2015 | 862 | 2015 |
| Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization GJ Weiner, HM Liu, JE Wooldridge, CE Dahle, AM Krieg Proceedings of the National Academy of Sciences 94 (20), 10833-10837, 1997 | 734 | 1997 |
| Cancer immunotherapy comes of age SL Topalian, GJ Weiner, DM Pardoll Journal of Clinical Oncology 29 (36), 4828-4836, 2011 | 649 | 2011 |
| Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines AM Krieg, G Weiner US Patent 6,218,371, 2001 | 457 | 2001 |
| Cancer and inflammation: promise for biologic therapy S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ... Journal of immunotherapy 33 (4), 335-351, 2010 | 424 | 2010 |
| Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge A Makkouk, GJ Weiner Cancer research 75 (1), 5-10, 2015 | 385 | 2015 |
| Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. KD Heckman, GJ Weiner, CS Davis, RG Strauss, MP Jones, CP Burns Journal of Clinical Oncology 15 (3), 1143-1149, 1997 | 376 | 1997 |
| Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs ZK Ballas, AM Krieg, T Warren, W Rasmussen, HL Davis, M Waldschmidt, ... The Journal of Immunology 167 (9), 4878-4886, 2001 | 355 | 2001 |
| Methods for enhancing antibody-induced cell lysis and treating cancer G Weiner, G Hartmann US Patent 7,534,772, 2009 | 301 | 2009 |
| Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma JE Wooldridge, Z Ballas, AM Krieg, GJ Weiner Blood, The Journal of the American Society of Hematology 89 (8), 2994-2998, 1997 | 291 | 1997 |
| Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab JA Bowles, SY Wang, BK Link, B Allan, G Beuerlein, MA Campbell, ... Blood 108 (8), 2648-2654, 2006 | 286 | 2006 |
| Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma MT Drake, MJ Maurer, BK Link, TM Habermann, SM Ansell, IN Micallef, ... Journal of clinical oncology 28 (27), 4191-4198, 2010 | 282 | 2010 |
| Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia SI Berndt, CF Skibola, V Joseph, NJ Camp, A Nieters, Z Wang, W Cozen, ... Nature genetics 45 (8), 868-876, 2013 | 257 | 2013 |
| NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement SY Wang, E Racila, RP Taylor, GJ Weiner Blood, The Journal of the American Society of Hematology 111 (3), 1456-1463, 2008 | 246 | 2008 |
| Early event status informs subsequent outcome in newly diagnosed follicular lymphoma MJ Maurer, E Bachy, H Ghesquières, SM Ansell, GS Nowakowski, ... American journal of hematology 91 (11), 1096-1101, 2016 | 234 | 2016 |
| Bispecific antibodies in cancer therapy DM Segal, GJ Weiner, LM Weiner Current opinion in immunology 11 (5), 558-562, 1999 | 233 | 1999 |
| Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion B Jahrsdörfer, A Vollmer, SE Blackwell, J Maier, K Sontheimer, T Beyer, ... Blood, The Journal of the American Society of Hematology 115 (6), 1156-1165, 2010 | 216 | 2010 |
| Uses of granulocyte-macrophage colony-stimulating factor in vaccine development TL Warren, GJ Weiner Current opinion in hematology 7 (3), 168-173, 2000 | 213 | 2000 |
Arthur M. KriegUniversity of Massachusetts Chan School of Medicine RNA Therapeutics InstituteEmail verificata su umassmed.edu
